These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 37861518)

  • 1. FTO, PIK3CB serve as potential markers to complement CEA and CA15-3 for the diagnosis of breast cancer.
    Mi J; Zhang H; Cao W; Yuan C
    Medicine (Baltimore); 2023 Oct; 102(42):e35361. PubMed ID: 37861518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Clinical Significance of sICAM-1 in Differentiating Benign Breast Lesions from Breast Cancer.
    Chen C; Chen Q; Dong Y; Liu X
    Ann Clin Lab Sci; 2020 Sep; 50(5):650-656. PubMed ID: 33067211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thioredoxin 1 as a serum marker for breast cancer and its use in combination with CEA or CA15-3 for improving the sensitivity of breast cancer diagnoses.
    Park BJ; Cha MK; Kim IH
    BMC Res Notes; 2014 Jan; 7():7. PubMed ID: 24393391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma mammaglobin messenger RNA in breast cancer patients as an addition to serum tumor.
    El-Attar NI; Gaefar HA
    Egypt J Immunol; 2007; 14(2):111-21. PubMed ID: 20306663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of serum microRNA-21 and miRNA-205 as diagnostic markers for stage I and II breast cancer in Indian population.
    Rama K; Bitla AR; Hulikal N; Yootla M; Yadagiri LA; Asha T; Manickavasagam M; Srinivasa Rao P
    Indian J Cancer; 2024 Apr; 61(2):290-298. PubMed ID: 38090957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination of Neutrophil-to-Lymphocyte Ratio and Red Cell Distribution Width With Serum Tumor Markers for the Differential Diagnosis of Breast Cancer and its Association With Pathological Features and Molecular Types.
    Zou H; Liu SH; Yang R; Wu XJ; Cao YP; Huang HF
    Clin Breast Cancer; 2022 Jun; 22(4):e526-e535. PubMed ID: 34963613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HER-2 gene amplification, serum nucleosomes, CEA and CA15.3 tumor markers in breast cancer patients.
    Zeiwar MM; Zaki SM; Mohammad LA; Zidan AA; El Nagar MR
    Egypt J Immunol; 2007; 14(2):29-41. PubMed ID: 20306655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Independent prognostic impact of preoperative serum carcinoembryonic antigen and cancer antigen 15-3 levels for early breast cancer subtypes.
    Imamura M; Morimoto T; Nomura T; Michishita S; Nishimukai A; Higuchi T; Fujimoto Y; Miyagawa Y; Kira A; Murase K; Araki K; Takatsuka Y; Oh K; Masai Y; Akazawa K; Miyoshi Y
    World J Surg Oncol; 2018 Feb; 16(1):26. PubMed ID: 29433529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nipple discharge of CA15-3, CA125, CEA and TSGF as a new biomarker panel for breast cancer.
    Wang G; Qin Y; Zhang J; Zhao J; Liang Y; Zhang Z; Qin M; Sun Y
    Int J Mol Sci; 2014 May; 15(6):9546-65. PubMed ID: 24879526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The diagnostic value of serum tumor markers CEA, CA19-9, CA125, CA15-3, and TPS in metastatic breast cancer.
    Wang W; Xu X; Tian B; Wang Y; Du L; Sun T; Shi Y; Zhao X; Jing J
    Clin Chim Acta; 2017 Jul; 470():51-55. PubMed ID: 28457854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual-Channel Detection of Breast Cancer Biomarkers CA15-3 and CEA in Human Serum Using Dialysis-Silicon Nanowire Field Effect Transistor.
    Li H; Wang S; Li X; Cheng C; Shen X; Wang T
    Int J Nanomedicine; 2022; 17():6289-6299. PubMed ID: 36536938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intensive post-operative follow-up of breast cancer patients with tumour markers: CEA, TPA or CA15.3 vs MCA and MCA-CA15.3 vs CEA-TPA-CA15.3 panel in the early detection of distant metastases.
    Nicolini A; Tartarelli G; Carpi A; Metelli MR; Ferrari P; Anselmi L; Conte M; Berti P; Miccoli P
    BMC Cancer; 2006 Nov; 6():269. PubMed ID: 17116247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The potential value of serum chemerin in patients with breast cancer.
    Song Y; Zhu X; Lin Z; Luo L; Wen D
    Sci Rep; 2021 Mar; 11(1):6564. PubMed ID: 33753802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of a novel assay for breast cancer mucin to CA15-3 and carcinoembryonic antigen.
    Daly L; Ferguson J; Cram GP; Hars V; George SL; McCarty KS; Bast RC
    J Clin Oncol; 1992 Jul; 10(7):1057-65. PubMed ID: 1607912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of TPS, CA125, CA15-3 and CEA in prediction of distant metastasis of breast cancer.
    Zhang J; Wei Q; Dong D; Ren L
    Clin Chim Acta; 2021 Dec; 523():19-25. PubMed ID: 34454906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating tumor DNA in Egyptian women with breast Cancer: A marker for detection of primary cases and early prediction of recurrence.
    Gameel AM; Talaat RM; Sakr MA; Selim MA; Abo Alil DFA; Elkhouly EA
    Clin Chim Acta; 2024 Aug; 562():119878. PubMed ID: 39047884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma cell-free DNA chromosomal instability analysis by low-pass whole-genome sequencing to monitor breast cancer relapse.
    Zhou H; Wang XJ; Jiang X; Qian Z; Chen T; Hu Y; Chen ZH; Gao Y; Wang R; Ye WW; Cao WM
    Breast Cancer Res Treat; 2019 Nov; 178(1):63-73. PubMed ID: 31364001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activated leukocyte cell adhesion molecule: a novel biomarker for breast cancer.
    Kulasingam V; Zheng Y; Soosaipillai A; Leon AE; Gion M; Diamandis EP
    Int J Cancer; 2009 Jul; 125(1):9-14. PubMed ID: 19322904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic Value of Serum Concentration and Integrity of Circulating Cell-Free DNA in Breast Cancer: A Comparative Study With CEA and CA15-3.
    Tang Z; Li L; Shen L; Shen X; Ju S; Cong H
    Lab Med; 2018 Oct; 49(4):323-328. PubMed ID: 29701836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of serum CA15-3 and CEA in breast cancer.
    Hou MF; Huang TJ; Hsieh JS; Huang YS; Huang CJ; Chan HM; Wang JY; Chen YL; Jong SB; Yang CC
    Gaoxiong Yi Xue Ke Xue Za Zhi; 1995 Dec; 11(12):660-6. PubMed ID: 8551526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.